We believe that Australian research is among the best in the world, yet there is a market failure at the heart of the Australian biotech market. SYNthesis BioVentures manages a fund (SYNthesis Bioventures Fund I) focused on early stage therapeutics, investing in projects from discovery through preclinical proof of concept and IND-enabling studies. We invest in small molecule therapeutics, biologics, and cell and gene therapies for indications with significant unmet need. By investing in projects from inception through to pre-IPO, we intend to facilitate the continuity of capital from Australian academia to venture financing and through Australian capital markets.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Melbourne, Victoria, Au
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Keywords
- Point Cook.
- HQ
- Melbourne, Victoria
Synthesis Bioventures Questions
Synthesis Bioventures's website is https://synthesisbioventures.com/
Synthesis Bioventures's LinkedIn profile is https://au.linkedin.com/company/synthesis-bioventures
Synthesis Bioventures has
3 employees.
View email and phone details for 3
employees at Synthesis Bioventures.
Synthesis Bioventures's industry is
Investment Management
Synthesis Bioventures's top competitors are
Trialkey,
Alithia Life Sciences,
Synthesis Med Chem,
Adjutor Healthcare Group,
Catalyst Therapeutics,
Apac Financial Services,
Oneventures,
Acclime,
Biocurate Pty Ltd,
Synthesis Research.
Synthesis Bioventures's categories are Investment Management
Synthesis Bioventures's founding year is 2022
